Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can better posture strengthen the pelvic floor in osteoporosis?

NCT ID NCT07806968

Disease control Sponsor: Cairo University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 08, 2026 · Last updated Sep 09, 2026 · Updated 1 time

Summary

This trial tests whether postural correction exercises can improve pelvic floor muscle function in postmenopausal women aged 55 to 65 who have osteoporosis and mild to moderate pelvic floor dysfunction. Participants receive estrogen replacement therapy and general posture advice, with some also doing targeted exercises. Researchers measure pelvic floor muscle activity, spinal curvature, and menopause-related quality of life before and after treatment.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Postural correction exercises combined with estrogen replacement therapy and general posture advice
What this could lead to
If effective, this approach could offer a non-invasive way to improve pelvic floor function and quality of life in postmenopausal women with osteoporosis.
What could go wrong
The trial is small and early, and results may not apply broadly. Exercise benefits can vary, and the added estrogen therapy carries its own risks.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 60 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Mar 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

55 to 65 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Postmenopausal women with ages between 55 and 65 years. * Their body mass index will not exceed 35 Kg/m2. * All women have mild to moderate pelvic floor muscle dysfunction. * All women were diagnosed with osteoporosis confirmed by Dual-energy X-ray Absorptiometry (DEXA) (T-score ≤ -2.5). Exclusion Criteria: * Women will be excluded if they have one or more of the following: * Previous pelvic or abdominal surgery affecting pelvic floor function. * Severe pelvic organ prolapse (Grade III or IV). * Neurological disorders affecting pelvic floor or lower limb function. * Severe musculoskeletal disorders limiting exercise participation. * Current participation in pelvic floor rehabilitation programs during the last 6 months. * Severe cardiovascular or respiratory conditions contraindicating exercise.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Osteoporosis are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

osteoporosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Osteoporosis Postmenopausal

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Cairo university

    Giza, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.